Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Heise

Showing results (81-90 of 272) with videos related to

Pageof 28
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2002
No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetesT Heise, S Bott, K Rave, et al.
Advanced Drug Delivery Reviews|December 14, 2020
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infectionCole J Batty, Mark T Heise, Eric M Bachelder, et al.
Diabetes Care|June 2, 2000
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placeboL Heinemann, R Linkeschova, K Rave, et al.
Diabetes Care|September 8, 2000
Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancerL Heinemann, W Klappoth, K Rave, et al.
Journal of Virology|March 16, 2005
Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86Mehul S Suthar, Reed Shabman, Kenya Madric, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 AspL Heinemann, C Weyer, K Rave, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2009
Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetesC Kapitza, T Heise, P Birman, et al.
Viruses|May 27, 2023
Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya EncephalomyelitisElizabeth J Anderson, Audrey C Knight, Mark T Heise, et al.
Annual Review of Virology|March 10, 2016
Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary PerspectivesKayla M Peck, Christina L Burch, Mark T Heise, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 1999
Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304L Heinemann, K Sinha, C Weyer, et al.
Pageof 28

Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Diabetic Medicine : a Journal of the British Diabetic Association|June 13, 2002
No evidence for accumulation of insulin glargine (LANTUS): a multiple injection study in patients with Type 1 diabetesT Heise, S Bott, K Rave, et al.
Advanced Drug Delivery Reviews|December 14, 2020
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infectionCole J Batty, Mark T Heise, Eric M Bachelder, et al.
Diabetes Care|June 2, 2000
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placeboL Heinemann, R Linkeschova, K Rave, et al.
Diabetes Care|September 8, 2000
Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancerL Heinemann, W Klappoth, K Rave, et al.
Journal of Virology|March 16, 2005
Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86Mehul S Suthar, Reed Shabman, Kenya Madric, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 AspL Heinemann, C Weyer, K Rave, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2009
Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetesC Kapitza, T Heise, P Birman, et al.
Viruses|May 27, 2023
Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya EncephalomyelitisElizabeth J Anderson, Audrey C Knight, Mark T Heise, et al.
Annual Review of Virology|March 10, 2016
Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary PerspectivesKayla M Peck, Christina L Burch, Mark T Heise, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 1999
Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304L Heinemann, K Sinha, C Weyer, et al.
Pageof 28